XML 26 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value of Financial Instruments
9 Months Ended
Oct. 03, 2020
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments

7. FAIR VALUE OF FINANCIAL INSTRUMENTS

The carrying value of cash and cash equivalents, accounts receivable, and short-term debt approximates fair value because of the short-term maturity of the instruments. Notes receivable are entered into in connection with the purchase of independent distributors’ distribution rights by independent distributor partners (“IDPs”). These notes receivable are recorded in the Condensed Consolidated Balance Sheets at carrying value, which represents the closest approximation of fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As a result, the appropriate interest rate that should be used to estimate the fair value of the distributor notes receivable is the prevailing market rate at which similar loans would be made to IDPs with similar credit ratings and for the same maturities. However, the company financed approximately 4,040 IDPs’ distribution rights as of October 3, 2020 and 4,200 as of December 28, 2019, respectively, all with varied financial histories and credit risks. Considering the diversity of credit risks among the IDPs, the company has no method to accurately determine a market interest rate to apply to the notes. The distribution rights are generally purchased by the IDP with a 5% down payment with the remainder financed for up to 10 years.  The distributor notes receivable are collateralized by the IDPs’ distribution rights. The company maintains a wholly-owned subsidiary to assist in financing the distribution rights purchase activities if requested by new IDPs, using the distribution rights and certain associated assets as collateral. These notes receivable earn interest at a fixed rate.

Interest income was primarily related to the IDPs’ notes receivable and was as follows (amounts in thousands):

 

 

 

Interest

Income

 

For the twelve weeks ended October 3, 2020

 

$

5,951

 

For the twelve weeks ended October 5, 2019

 

$

6,371

 

For the forty weeks ended October 3, 2020

 

$

20,408

 

For the forty weeks ended October 5, 2019

 

$

21,441

 

 

At October 3, 2020 and December 28, 2019, respectively, the carrying value of the distributor notes receivable was as follows (amounts in thousands):

 

 

 

October 3, 2020

 

 

December 28, 2019

 

Distributor notes receivable

 

$

210,352

 

 

$

226,348

 

Current portion of distributor notes receivable recorded in

   accounts and notes receivable, net

 

 

28,291

 

 

 

27,709

 

Long-term portion of distributor notes receivable

 

$

182,061

 

 

$

198,639

 

 

At October 3, 2020 and December 28, 2019, respectively, the company has evaluated the collectability of the distributor notes receivable and determined that a reserve is not necessary. Payments on these distributor notes receivable are collected by the company weekly in conjunction with the distributor settlement process.

The fair value of the company’s variable rate debt at October 3, 2020 is presented below. The fair value of the company’s 3.5% senior notes due 2026 (“2026 notes”) and 4.375% senior notes due 2022 (“2022 notes”), as discussed in Note 12, Debt and Other Obligations, of Notes to Condensed Consolidated Financial Statements of this Form 10-Q are estimated using yields obtained from independent pricing sources for similar types of borrowing arrangements and are considered a Level 2 valuation. The fair value of the 2026 notes and 2022 notes are presented in the table below (amounts in thousands, except level classification):

 

 

 

Carrying Value

 

 

Fair Value

 

 

Level

2026 notes

 

$

396,562

 

 

$

433,772

 

 

2

2022 notes

 

$

399,277

 

 

$

414,664

 

 

2

 

For fair value disclosure information about our derivative assets and liabilities see Note 8, Derivative Financial Instruments, of Notes to Condensed Consolidated Financial Statements of this Form 10-Q.